(Q35976425)

11 August 2017

0 references

Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens (English)

1 reference

11 August 2017

1 reference

0 references

1 reference

A'Hern RP

1

1 reference

11 August 2017

Smith IE

series ordinal

2

1 reference

11 August 2017

Ebbs SR

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 April 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

67

1 reference

11 August 2017

801-805

1 reference

11 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1993.146

11 August 2017

0 references

cites work

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968345

A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer A Cancer and Leukemia Group B study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968345

Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968345

Does chemotherapy improve survival in advanced breast cancer? A statistical overview

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968345

The size of clinical trials in cancer research--what are the current needs? Medical Research Council Cancer Therapy Committee

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968345

Can meta-analyses be trusted?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968345

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968345

A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer

2 October 2017

1 reference

12 December 2020

Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B

1 reference

12 December 2020

A comparison of statistical methods for combining event rates from clinical trials

1 reference

12 December 2020

How American oncologists treat breast cancer: an assessment of the influence of clinical trials

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.146

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference